Received Apr 1, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | UNK | — |
Shingrix vaccine off label; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of off label use in a patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced off label use (Verbatim: Shingrix vaccine off label). The outcome of the off label use was not applicable. Additional Information: GSK Receipt Date: 21-MAR-2026 This case was reported by a consumer via interactive digital media. The batch number was not provided and unable to contact the reporter.